Free tool
FAERS Monitor: Viagra
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020895 or its brand name (Viagra, Sildenafil Citrate). Reports on generic versions are filed under their own applications.
Reports
60,910
Serious
33,452
55% of reports
Hospitalization
14,032
Death reported
4,495
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective10,621
- headache5,105
- dyspnoea4,383
- erection increased2,999
- diarrhoea2,910
- fatigue2,797
- nausea2,676
- dizziness2,602
- cough2,306
- death2,187
- pain1,820
- malaise1,689
- off label use1,594
- flushing1,479
- hypotension1,463
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 987 |
| 2005 | 1,340 |
| 2006 | 1,598 |
| 2007 | 955 |
| 2008 | 924 |
| 2009 | 894 |
| 2010 | 4,072 |
| 2011 | 2,002 |
| 2012 | 2,790 |
| 2013 | 2,909 |
| 2014 | 3,394 |
| 2015 | 4,061 |
| 2016 | 4,002 |
| 2017 | 4,367 |
| 2018 | 3,396 |
| 2019 | 4,504 |
| 2020 | 3,692 |
| 2021 | 2,619 |
| 2022 | 2,638 |
| 2023 | 2,543 |
| 2024 | 2,613 |
| 2025 | 2,606 |
| 2026 | 2,004 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,993,249 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| erection increasedSignal | 2,999 | 870.1 | 813.9 | 738,555 |
| flushingSignal | 1,479 | 5.1 | 4.8 | 4,799 |
| coughSignal | 2,306 | 2.9 | 2.7 | 2,791 |
| headacheSignal | 5,105 | 2.8 | 2.8 | 6,158 |
| drug ineffectiveSignal | 10,621 | 2.8 | 2.7 | 12,978 |
| dyspnoeaSignal | 4,383 | 2.7 | 2.6 | 4,731 |
| hypotensionSignal | 1,463 | 2.5 | 2.4 | 1,355 |
| dizziness | 2,602 | 1.8 | 1.7 | 952 |
| diarrhoea | 2,910 | 1.6 | 1.5 | 599 |
| malaise | 1,689 | 1.3 | 1.3 | 141 |
| fatigue | 2,797 | 1.2 | 1.2 | 136 |
| nausea | 2,676 | 1.2 | 1.1 | 67 |
| pain | 1,820 | 1.0 | 1.0 | 1 |
| death | 2,187 | 0.9 | 0.8 | 40 |
| off label use | 1,594 | 0.6 | 0.6 | 366 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.